Skip to content
Recall Observatory FDA recall evidence

Drug product

Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.

D-1180-2022

March 16, 2022

Class II

Product summary

Firm
Golden State Medical Supply Inc.
Event
Event 89863
Status
Ongoing
Classification
Class II
Quantity
1,424 bottles
Official record key
drug-enforcement:D-1180-2022

Official wording

Reason: CGMP Deviations

Code information: Lots: GS035031, GS035199, 20 mg; 90 tablets, Exp.: 03/2022; Lots: GS036495, GS036904, Exp.: 05/2022; Lots: GS037401, Exp.: 09/2022; Lots: GS037986, GS038359, GS039560, Exp.: 11/2022; Lot: GS041110, Exp.: 12/2022. (NDC: 60429-186-90).

Distribution pattern: Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations